Cardiomyocyte contractile status is associated with differences in fibronectin and integrin interactions.
Integrins link the extracellular matrix (ECM) with the intracellular cytoskeleton and other cell adhesion-associated signaling proteins to function as mechanotransducers. However, direct quantitative measurements of the cardiomyocyte mechanical state and its relationship to the interactions between specific ECM proteins and integrins are lacking. The purpose of this study was to characterize the interactions between the ECM protein fibronectin (FN) and integrins in cardiomyocytes and to test the hypothesis that these interactions would vary during contraction and relaxation states in cardiomyocytes. Using atomic force microscopy, we quantified the unbinding force (adhesion force) and adhesion probability between integrins and FN and correlated these measurements with the contractile state as indexed by cell stiffness on freshly isolated mouse cardiomyocytes. Experiments were performed in normal physiological (control), high-K(+) (tonically contracted), or low-Ca(2+) (fully relaxed) solutions. Under control conditions, the initial peak of adhesion force between FN and myocyte alpha(3)beta(1)- and/or alpha(5)beta(1)-integrins was 39.6 +/- 1.3 pN. The binding specificity between FN and alpha(3)beta(1)- and alpha(5)beta(1)-integrins was verified by using monoclonal antibodies against alpha(3)-, alpha(5)-, alpha(3) + alpha(5)-, or beta(1)-integrin subunits, which inhibited binding by 48%, 65%, 70%, or 75%, respectively. Cytochalasin D or 2,3-butanedione monoxime (BDM), to disrupt the actin cytoskeleton or block myofilament function, respectively, significantly decreased the cell stiffness; however, the adhesion force and binding probability were not altered. Tonic contraction with high-K(+) solution increased total cell adhesion (1.2-fold) and cell stiffness (27.5-fold) compared with fully relaxed cells with low-Ca(2+) solution. However, it could be partially prevented by high-K(+) bath solution containing BDM, which suppresses contraction by inhibiting the actin-myosin interactions. Thus, our results demonstrate that integrin binding to FN is modulated by the contractile state of cardiac myocytes.
Wu
Xin
X
Dept. of Systems Biology and Translational Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX 77843-1114, USA.
Sun
Zhe
Z
Foskett
Andrea
A
Trzeciakowski
Jerome P
JP
Meininger
Gerald A
GA
Muthuchamy
Mariappan
M
D000199:Actins / Q000502:physiology; D000818:Animals; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000502:physiology; D005109:Extracellular Matrix / Q000502:physiology; D005353:Fibronectins / Q000502:physiology*; D016023:Integrins / Q000502:physiology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D023421:Models, Animal; D009200:Myocardial Contraction / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000502:physiology*; D009218:Myosins / Q000502:physiology
D000199:Actins; D005353:Fibronectins; D016023:Integrins; D009218:Myosins
Am J Cardiol. 1999 Jun 17;83(12A):38H-43H
10750585
J Cell Sci. 2008 Jun 1;121(11):1785-91
18492792
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2291-301
16284104
Curr Opin Cell Biol. 1991 Oct;3(5):786-91
1931080
Proc Natl Acad Sci U S A. 1983 Feb;80(4):1008-12
6405378
Annu Rev Cell Biol. 1987;3:57-85
3318883
Cell Motil. 1983;3(5-6):449-62
6420066
Soc Gen Physiol Ser. 1997;52:209-18
9210231
J Mol Cell Cardiol. 2001 Mar;33(3):521-32
11181020
Cardiovasc Res. 2004 Aug 1;63(2):283-92
15249186
Circulation. 2003 Feb 25;107(7):1046-52
12600920
Biophys J. 2003 Feb;84(2 Pt 1):1252-62
12547805
Nat Chem Biol. 2009 Jun;5(6):383-90
19448607
Circulation. 1997 Dec 2;96(11):4065-82
9403633
J Biol Chem. 1997 Feb 14;272(7):4500-8
9020175
Nat Struct Biol. 2001 May;8(5):412-6
11323715
Science. 1995 Feb 10;267(5199):883-5
7846531
Nat Rev Mol Cell Biol. 2001 Nov;2(11):793-805
11715046
J Cell Biol. 1995 Nov;131(3):791-805
7593197
Am J Physiol. 1996 Sep;271(3 Pt 2):H1250-5
8853365
Curr Hypertens Rep. 2004 Dec;6(6):424-9
15527685
Circ Res. 2001 Jun 8;88(11):1112-9
11397776
J Pathol. 1996 Jul;179(3):321-5
8774490
J Physiol. 2004 Oct 15;560(Pt 2):403-11
15297568
Biophys J. 2005 Dec;89(6):4320-9
16183875
Heart Fail Rev. 2000 Oct;5(3):239-50
16228907
J Biol Chem. 1998 Feb 27;273(9):5081-5
9478959
Cell. 2003 Jan 24;112(2):147-50
12553903
Science. 1993 May 21;260(5111):1124-7
7684161
Circ Res. 1991 Nov;69(5):1280-92
1934358
Curr Opin Cell Biol. 1991 Oct;3(5):841-8
1931084
J Clin Invest. 1968 Sep;47(9):1973-99
5675423
Lab Invest. 1991 Jan;64(1):65-75
1824954
J Biol Chem. 2006 May 19;281(20):14015-25
16554304
Cardiovasc Res. 2006 Jun 1;70(3):422-33
16466704
Nat Cell Biol. 2000 Jun;2(6):313-7
10854320
J Mol Cell Cardiol. 2001 Mar;33(3):487-501
11181017
Cell Biol Int. 1997 Nov;21(11):685-96
9817809
Am J Physiol Cell Physiol. 2008 Jul;295(1):C268-78
18495809
Biophys J. 2005 Oct;89(4):2888-98
16055535
Biochem Biophys Res Commun. 1999 Jun 16;259(3):645-50
10364472
J Cell Biol. 1993 May;121(3):673-8
8387531
Cardiovasc Res. 2004 Aug 15;63(3):381-90
15276463
Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1427-33
11247750
Proc Natl Acad Sci U S A. 1990 Jan;87(1):404-8
2296596
Cardiovasc Pathol. 2004 Jan-Feb;13(1):11-9
14761780
Exp Biol Med (Maywood). 2004 Jun;229(6):538-45
15169973
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2526-35
16100245
J Mol Cell Cardiol. 1997 Sep;29(9):2533-43
9299376
J Clin Invest. 1992 Feb;89(2):392-401
1531344
J Physiol. 2005 Apr 15;564(Pt 2):603-17
15718258
J Physiol. 2008 Mar 15;586(6):1699-713
18218680
Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1363-70
9743223
J Biol Chem. 2001 Aug 10;276(32):30285-92
11382763
Cardiovasc Res. 2000 Jul;47(1):23-37
10869527
Diabetes. 2006 Nov;55(11):3104-11
17065349
Physiol Genomics. 2004 Aug 11;18(3):273-83
15306692
Dev Dyn. 2004 Sep;231(1):179-89
15305298
J Clin Invest. 1991 Nov;88(5):1737-46
1834701
J Biol Chem. 2003 Apr 18;278(16):13591-4
12556452
Circ Res. 1997 Feb;80(2):281-9
9012750
Cell. 1992 Apr 3;69(1):11-25
1555235
J Mol Cell Cardiol. 1998 May;30(5):947-55
9618235
J Cell Biol. 1998 Oct 5;143(1):241-52
9763435
Annu Rev Physiol. 1997;59:551-71
9074777
Circ Res. 2006 Dec 8;99(12):1403-10
17095723
J Clin Invest. 1992 Apr;89(4):1060-8
1556175
Cardiovasc Res. 1996 Sep;32(3):433-42
8881506
Trends Pharmacol Sci. 2001 May;22(5):254-60
11339977
J Cell Physiol. 1988 Jul;136(1):43-53
3294238
Am J Physiol. 1995 Jul;269(1 Pt 1):C286-92
7631757
Sci Am. 1986 Jun;254(6):42-51
3010451
Biochemistry. 2001 Nov 20;40(46):13915-24
11705381
Am J Physiol. 1992 Jun;262(6 Pt 2):H1861-6
1535758
J Cell Physiol. 2001 Oct;189(1):1-13
11573199
J Histochem Cytochem. 1984 Apr;32(4):383-8
6707462
Diabetes. 2005 Jun;54(6):1615-25
15919781
Circ Res. 2002 Jan 11;90(1):11-3
11786511